These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9624313)

  • 41. [Is GHB use in Switzerland on the rise?].
    Pfeifer HR; Stohler R
    Praxis (Bern 1994); 2004 Jul; 93(31-32):1247-9. PubMed ID: 15453147
    [No Abstract]   [Full Text] [Related]  

  • 42. The Xyrem risk management program.
    Fuller DE; Hornfeldt CS; Kelloway JS; Stahl PJ; Anderson TF
    Drug Saf; 2004; 27(5):293-306. PubMed ID: 15061684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
    Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
    Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.
    Carter LP; Pardi D; Gorsline J; Griffiths RR
    Drug Alcohol Depend; 2009 Sep; 104(1-2):1-10. PubMed ID: 19493637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam.
    Smith MA; Gergans SR; Lyle MA
    Eur J Pharmacol; 2006 Dec; 552(1-3):83-9. PubMed ID: 17026996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agitation is common in gamma-hydroxybutyrate toxicity.
    Zvosec DL; Smith SW
    Am J Emerg Med; 2005 May; 23(3):316-20. PubMed ID: 15915404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium oxybate for narcolepsy.
    Scharf MB
    Expert Rev Neurother; 2006 Aug; 6(8):1139-46. PubMed ID: 16893342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-medication with gamma-hydroxybutyrate to reduce alcohol intake.
    Glisson JK; Norton J
    South Med J; 2002 Aug; 95(8):926-8. PubMed ID: 12190234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiogenic-like effects of gamma-hydroxybutyric acid (GHB) in mice tested in the light-dark box.
    Navarro JF; Dávila G; Pedraza C; Arias JL
    Psicothema; 2008 Aug; 20(3):460-4. PubMed ID: 18674444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical submission: GHB, benzodiazepines, and other knock out drops.
    Bismuth C; Dally S; Borron SW
    J Toxicol Clin Toxicol; 1997; 35(6):595-8. PubMed ID: 9365425
    [No Abstract]   [Full Text] [Related]  

  • 53. Insufficient evidence that agitation is common in gamma-hydroxybutyrate toxicity.
    Wood D; Gawarammana I; Greene S; Dargan P; Jones A
    Am J Emerg Med; 2006 Mar; 24(2):257. PubMed ID: 16490668
    [No Abstract]   [Full Text] [Related]  

  • 54. High mortality rates among GHB abusers in Western Sweden.
    Knudsen K; Greter J; Verdicchio M
    Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand.
    Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A
    J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GHB: a new and novel drug of abuse.
    Nicholson KL; Balster RL
    Drug Alcohol Depend; 2001 Jun; 63(1):1-22. PubMed ID: 11297827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
    Abanades S; Farré M; Segura M; Pichini S; Barral D; Pacifici R; Pellegrini M; Fonseca F; Langohr K; De La Torre R
    Ann N Y Acad Sci; 2006 Aug; 1074():559-76. PubMed ID: 17105953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden].
    Knudsen K; Greter J; Verdicchio M; Cederquist T
    Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning.
    Sircar R; Basak A
    Pharmacol Biochem Behav; 2004 Dec; 79(4):701-8. PubMed ID: 15582677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.